XDEMVY Experts: Real-World Patient and OD Perspectives

Come hear from patients and physicians who have first-hand experience with FDA-approved XDEMVY (lotilaner ophthalmic solution) 0.25%.
Reception and dinner will be provided.

Friday, November 8, 2024

7:00–9:00 PM ET

Commission Row
110 S Delaware St
Indianapolis, IN 46204

OD Experts: